Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationMultiple MyelomaHematopoietic Stem Cell MobilizationMelphalanTransplantation ConditioningTransplantation, HomologousGranulocyte Colony-Stimulating FactorLeukapheresisAntigens, CD34Blood Component RemovalCombined Modality TherapyHematologic NeoplasmsBone Marrow TransplantationStem Cell TransplantationCyclophosphamideAntineoplastic Combined Chemotherapy ProtocolsHematopoietic Stem CellsGraft vs Host DiseaseBusulfanTreatment OutcomeMyeloablative AgonistsBone MarrowGraft SurvivalStem CellsLymphoma, Non-HodgkinRemission InductionAntineoplastic Agents, AlkylatingEtoposideThiotepaRecurrenceBone Marrow CellsSalvage TherapyVincristineHematopoiesisCarmustineIfosfamideDisease-Free SurvivalCord Blood Stem Cell TransplantationCytophagocytosisAmyloidosisTransplantation ChimeraTissue DonorsCytarabineSurvival RateRetrospective StudiesHodgkin DiseaseWhole-Body IrradiationDexamethasoneSurvival AnalysisTime FactorsNeoplasmsDoxorubicinBoronic AcidsPrednisoneBlood Cell CountPyrazinesThalidomideHistocompatibilityBlood CellsBone Marrow PurgingInfectionPlatelet CountPOEMS SyndromeHistocompatibility TestingLeukemiaAntineoplastic AgentsImmunosuppressive AgentsLeukemia, Myeloid, AcuteTransplantation, IsogeneicLymphoma, T-CellVidarabineRecombinant ProteinsImmunophenotypingCarboplatinFollow-Up StudiesLymphomaBone Marrow DiseasesFlow CytometryCytomegalovirus InfectionsAnemia, AplasticProspective StudiesFeasibility StudiesFatal OutcomePrognosisPlasma CellsGraft vs Leukemia EffectMyelodysplastic SyndromesLeukocytes, MononuclearCell SeparationBlood DonorsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte DepletionT-LymphocytesHematologic DiseasesAntigens, CDCells, CulturedHistiocytosis, Non-Langerhans-CellLeukocyte Count